Format

Send to

Choose Destination
Med Sci (Paris). 2020 Jan;36(1):83-86. doi: 10.1051/medsci/2019263. Epub 2020 Feb 4.

[Non-mutated neoantigens, TEIPP, as new targets for cancer immunotherapies].

[Article in French]

Author information

1
Master 1 cancer, module d'immunologie-virologie, université de Lyon, université Claude Bernard Lyon 1, Lyon, France.
2
UMR Inserm 1052, CNRS 5286, centre Léon Bérard, centre de recherche en cancérologie de Lyon, 28 rue Laennec 69373 Lyon cedex 08, France.
PMID:
32014105
DOI:
10.1051/medsci/2019263

Supplemental Content

Full text links

Icon for EDP Sciences
Loading ...
Support Center